310 related articles for article (PubMed ID: 24066796)
1. Cancer vaccination by electro-gene-transfer.
Aurisicchio L; Mancini R; Ciliberto G
Expert Rev Vaccines; 2013 Oct; 12(10):1127-37. PubMed ID: 24066796
[TBL] [Abstract][Full Text] [Related]
2. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines, electroporation and their applications in cancer treatment.
Lee SH; Danishmalik SN; Sin JI
Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
[TBL] [Abstract][Full Text] [Related]
4. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination against tumors.
Prud'homme GJ
J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
[TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
Weide B; Garbe C; Rammensee HG; Pascolo S
Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
[TBL] [Abstract][Full Text] [Related]
7. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D
Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma.
Smorlesi A; Papalini F; Amici A; Orlando F; Pierpaoli S; Mancini C; Provinciali M
Vaccine; 2006 Mar; 24(11):1766-75. PubMed ID: 16288939
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments.
Shoji M; Katayama K; Tachibana M; Tomita K; Sakurai F; Kawabata K; Mizuguchi H
Vaccine; 2012 Nov; 30(50):7278-85. PubMed ID: 23036499
[TBL] [Abstract][Full Text] [Related]
10. [Advances in the researches of DNA vaccines against tumors].
Lu Y; Tian L; Wei Y; Yang L; Zhao X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):288-90. PubMed ID: 10932018
[TBL] [Abstract][Full Text] [Related]
11. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
12. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.
Otten GR; Schaefer M; Doe B; Liu H; Megede JZ; Donnelly J; Rabussay D; Barnett S; Ulmer JB
Vaccine; 2006 May; 24(21):4503-9. PubMed ID: 16181711
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
Bodles-Brakhop AM; Draghia-Akli R
Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines: an historical perspective and view to the future.
Liu MA
Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
[TBL] [Abstract][Full Text] [Related]
16. The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination.
Parvanova I; Rettig L; Knuth A; Pascolo S
Vaccine; 2011 May; 29(22):3832-6. PubMed ID: 21470580
[TBL] [Abstract][Full Text] [Related]
17. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
[TBL] [Abstract][Full Text] [Related]
18. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
[TBL] [Abstract][Full Text] [Related]
19. Electro-gene-transfer as a new tool for cancer immunotherapy in animals.
Impellizeri JA; Ciliberto G; Aurisicchio L
Vet Comp Oncol; 2014 Dec; 12(4):310-8. PubMed ID: 23095099
[TBL] [Abstract][Full Text] [Related]
20. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
